Optimization of the Inclusion of Alzheimer's Disease Patients in International Multicenter Randomized Trials: Results of a National Survey Conducted in Memory Research Centers in France

Publisher： Karger

E-ISSN： 1664-5464|3|1|417-425

ISSN： 1664-5464

Source： Dementia and Geriatric Cognitive Disorders Extra, Vol.3, Iss.1, 2013-11, pp. : 417-425

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Term Safety and Efficacy of Donepezil in Patients with Severe Alzheimer’s Disease: Results from a 52-Week, Open-Label, Multicenter, Extension Study in Japan

By  

Dementia and Geriatric Cognitive Disorders, Vol. 27, Iss. 3, 2009-02 ,pp. : 232-239

Karger

Access to resources Recommend Favorite

Key Methodological Features of Randomized Controlled Trials of Alzheimer’s Disease Therapy

By  

Dementia and Geriatric Cognitive Disorders, Vol. 10, Iss. 6, 1999-11 ,pp. : 534-540

Karger

Access to resources Recommend Favorite

Emotional Working Memory in Alzheimer’s Disease Patients

By  

Dementia and Geriatric Cognitive Disorders Extra, Vol. 1, Iss. 1, 2011-06 ,pp. : 124-138

Karger

Access to resources Recommend Favorite

Donepezil Treatment of Patients with Severe Alzheimer’s Disease in a Japanese Population: Results from a 24-Week, Double-Blind, Placebo-Controlled, Randomized Trial

By  

Dementia and Geriatric Cognitive Disorders, Vol. 25, Iss. 5, 2008-04 ,pp. : 399-407

Karger

Access to resources Recommend Favorite

Effectiveness and Safety of MLC601 in the Treatment of Mild to Moderate Alzheimer's Disease: A Multicenter, Randomized Controlled Trial

By  

Dementia and Geriatric Cognitive Disorders Extra, Vol. 5, Iss. 1, 2015-03 ,pp. : 96-106

Karger

Access to resources Recommend Favorite